These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 317699)

  • 21. Anti-inflammatory and other pharmacodynamic properties of five members of the 4-aryl-1-isopropyl-2(1H)-quinazolinone series.
    Perrine JW; Houlihan WJ; Takesue EI
    Arzneimittelforschung; 1984; 34(8):879-85. PubMed ID: 6333879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological actions and acute toxicity of methyl- and phenyl-3-methoxy-4-hydroxy styryl ketones.
    Singh GB; Leach GD; Atal CK
    Arzneimittelforschung; 1987 Jun; 37(6):708-12. PubMed ID: 3663269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease.
    Avramidis N; Kourounakis A; Hadjipetrou L; Senchuk V
    Arzneimittelforschung; 1998 Jul; 48(7):764-71. PubMed ID: 9706378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological studies of a new antitussive, 1-phenethyl-4-hydroxy-salicylamido-4-methyl-piperidine-hydrochloride (S 1592) (author's transl)].
    Duhault J; Tisserand F; Regnier G
    Arzneimittelforschung; 1976 Apr; 26(4):516-23. PubMed ID: 989005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of L-cysteine and S-methyl-L-cysteine derivatives of immunotropic and anti-inflammatory activity.
    Kwapiszewski W; Sokołowska-Muszyńska M; Iliaszenko J
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):729-31. PubMed ID: 549529
    [No Abstract]   [Full Text] [Related]  

  • 26. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis.
    Saso Y; Conner EM; Teegarden BR; Yuan CS
    J Pharmacol Exp Ther; 2001 Jan; 296(1):106-12. PubMed ID: 11123369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M2000: a revolution in pharmacology.
    Mirshafiey A; Cuzzocrea S; Rehm BH; Matsuo H
    Med Sci Monit; 2005 Aug; 11(8):PI53-63. PubMed ID: 16049391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General pharmacological properties of muroctasin.
    Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
    Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological activities and side effects of plafibride.
    Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.
    Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y
    Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of L-cysteine derivatives of immunotropic activity.
    Kwapiszewski W; Iliaszenko J; Sokołowska-Muszyńska M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):917-9. PubMed ID: 749840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [General pharmacological effects of flupentixol].
    Ueki S; Watanabe S; Morimot Y; Masuda M
    Igaku Kenkyu; 1971 Jul; 41(5):441-51. PubMed ID: 5165981
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the influence of cysteine derivatives on the cell-mediated immunity.
    Ryzewski J; Kossakowska M; Chwaliński S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):801-4. PubMed ID: 7349100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the anti-inflammatory and immunotropic effect of gold salts.
    Giełdanowski J; Doskocz W; Skowrońska J
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):287-94. PubMed ID: 6525026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental therapy of adjuvant disease].
    Saratikov AA; Vengerovskiĭ AI
    Farmakol Toksikol; 1983; 46(1):116-20. PubMed ID: 6337869
    [No Abstract]   [Full Text] [Related]  

  • 38. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the pharmacodynamics of acemetacin (author's transl)].
    Jacobi H; Dell HD
    Arzneimittelforschung; 1980; 30(8A):1348-62. PubMed ID: 6968219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.